Trademark Overview
On Tuesday, December 17, 2024, a trademark application was filed for KARINOSEA with the United States Patent and Trademark Office. The USPTO has given the KARINOSEA trademark a serial number of 98907712. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 17, 2024. The KARINOSEA trademark is filed in the Pharmaceutical Products category with the following description:
Anti-diabetic pharmaceuticals; Chondroitin preparations; Cod liver oil; Coenzyme Q10 dietary supplements; Dietary food supplements; Mineral dietary supplements; Nutraceuticals for use as a dietary supplement; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Probiotic supplements; Vitamin and mineral supplements
